InsidersTradesSigma
Explore the complete record of transactions filed by YOUNG JAMES F, Director. Officer active across 1 companies, notably NOVAVAX INC. Aggregated, 8 disclosures have been published. Total volume traded: €592k. The latest transaction was disclosed on 31 March 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
8 of 8 declarations
James F. Young is a Board Member at Novavax Inc. In this role, he contributes to the governance of the company by bringing his expertise in the biopharmaceutical sector. James plays a key role in evaluating the company's performance and overseeing growth strategies. His industry experience is a valuable asset to Novavax's management team.